Seminars in Plastic Surgery 2019; 33(04): 264-269
DOI: 10.1055/s-0039-1697028
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Update in Direct-to-Implant Breast Reconstruction

Aurelia Trisliana Perdanasari
1  Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Amjed Abu-Ghname
1  Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Sarth Raj
1  Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Sebastian J. Winocour
1  Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Rene D. Largo
2  Department of Plastic Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
17 October 2019 (online)

Abstract

Implant-based reconstruction (IBR) remains the most commonly utilized breast reconstruction option for post-mastectomy patients. IBR can be approached as either a one-stage reconstruction or a two-stage reconstruction. Facilitated by improvements in surgical technology and advanced techniques, one-stage reconstruction, also known as direct-to-implant (DTI) reconstruction, involves the insertion of an implant at the time of mastectomy. The decision to pursue either a DTI or a two-stage reconstruction is based on several factors, including the patient's overall health, expected risk of postoperative complications, and associated costs to both the patient and hospital.

Financial Disclosures

None of the authors of this manuscript have a financial interest in any of the products, devices, or drugs mentioned herein.